Necrobiotic xanthogranuloma with paraproteinemia: an evolving presentation

Area of Science:

• Dermatology
• Pathology
• Immunology

Background:

• Necrobiotic xanthogranuloma with paraproteinemia (NXG) is a rare, destructive disorder.
• It is frequently misdiagnosed due to overlapping clinical and histological features with other granulomatous and xanthomatous conditions.
• Previously reported under various names, it was first described as NXG in 1980.

Observation:

• A 69-year-old woman presented with pruritic, painful papules, plaques, and nodules.
• Initial biopsies suggested granuloma annulare, followed by changes consistent with necrobiosis lipoidica.
• Subsequent biopsies confirmed necrobiotic xanthogranuloma with coexistent IgG kappa paraproteinemia.

Findings:

• NXG is a progressive, destructive process.
• Histological findings can evolve over time, leading to diagnostic challenges.
• Patients with NXG and monoclonal gammopathy have a 9-11% risk of developing myeloma, amyloidosis, or macroglobulinemia.

Implications:

• Early and accurate diagnosis of NXG is crucial for patient management.
• The proposed evolutionary process suggests a link between granulomatous conditions and xanthogranuloma with paraproteinemia.
• Current treatment regimens are not curative, highlighting the need for further research into effective therapies.